Global Bioabsorbable Stents Market Size (2024 - 2029)

The bioabsorbable stents market is projected to experience significant growth over the forecast period, driven by an increasing prevalence of cardiovascular diseases, a rising aging population, and a growing obese population. These factors are expected to expand the market's scope and demand for early diagnosis and treatment. Additionally, product launches by key market players are anticipated to further propel market growth. However, challenges such as stringent regulatory requirements, high device costs, and safety concerns may restrain the market's expansion.

Market Size of Global Bioabsorbable Stents Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Bioabsorbable Stents Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.08 Billion
Market Size (2029) USD 1.63 Billion
CAGR (2024 - 2029) 8.76 %
Fastest Growing Market North America
Largest Market Europe

Major Players

Bioabsorbable Stents Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Bioabsorbable Stents Market Analysis

The Global Bioabsorbable Stents Market size is estimated at USD 1.08 billion in 2024, and is expected to reach USD 1.63 billion by 2029, growing at a CAGR of 8.76% during the forecast period (2024-2029).

The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on health care and cardiac surgery. As per the Society of Thoracic Surgeons (STS) database in February 2021, Cardiac surgery volumes in the United States fell by more than half during the COVID-19 pandemic's first wave, with the biggest drops observed in the New England and mid-Atlantic regions. Other studies that looked at the early weeks and months of COVID-19 found that when hospitals' services were shut down or severely limited and patients were hesitant to seek help there were widespread cardiac effects such as missed ST-segment elevation myocardial infarction (STEMIs), higher rates of cardiac arrest, and fewer diagnostic and elective procedures. Thus, the decline in the cardiac surgery volume significantly impacted the market growth.

Factors that are driving the market include a high prevalence of cardiovascular diseases, steep increase in the aging population, and the expanding base of the obese population. For instance, according to a World Health Organization article published July 2021, an estimated 17.9 million people worldwide die from heart disease each year. This represents 31% of deaths worldwide, and 85% of these deaths are mainly caused by heart disease and stroke. This high prevalence of cardiovascular diseases and deaths associated to it are expected to drive demand for early diagnosis and treatment, which will expand the scope of the market studied and boost its market growth over the forecast period.

Furthermore rise in geriatric population who are more prone towards the chronic diseases such as heart diseases anticipated to boost the market demand. According to the World Health Organization Facts of October 2021, the proportion of the global population aged 60 and up will nearly double from 12% to 22% between 2015 and 2050. By 2050, 80% of the world's elderly will live in low- and middle-income countries. The population is ageing at a much faster rate than in the past. Every country faces significant challenges in ensuring that its health and social systems are prepared to take advantage of this demographic shift.

In addition, growing base of obese population bolster the bioabsorbable stent demand boost the market growth over the forecast period. According to the World Health Organization's report published in June 2021, 39 million children under the age of 5 years were overweight or obese in 2020. Incidences of obesity have been increasing fiercely over the past decades, and it is often described as a global endemic, especially in developed countries where lifestyle-related disorders, such as anxiety, stress, smoking, and drinking, are more prevalent. Thus, increasing in the prevalence of obesity makes patients more prone towards the heart diseases thereby expected to boosting the market growth.

However, growing product launches by the key market players anticipated to boost the market growth. For Instance, in December 2021, Svelte Medical Systems received United States Food and Drug Administration (FDA) approval to commercialize the SLENDER IDS fixed-wire and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems for the treatment of coronary artery disease in the United States.

Thus, all aforementioned factors anticipated to boost the market growth over the forecast period. However, stringent regulatory scenario, high cost of devices as well as safety issues restraint the market over the forecast period.

Bioabsorbable Stents Industry Segmentation

As per the scope of the report, in medicine, a stent is any device that is inserted into a blood vessel or other internal duct to expand it to prevent or alleviate a blockage. Traditionally, such devices are fabricated from metal mesh and remain in the body permanently or until removed through further surgical intervention. Bioresorbable stent (BRS) devices are coronary stents that can fully dissolve in the body. The Bioabsorbable Stents Market is segmented by Product Type (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Application (Coronary Artery Disease, Peripheral Artery Disease) Absorption Rate (Slow absorption Rate, Fast absorption Rate), End User (Hospital and Other end User), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents
By Application
Coronary Artery Disease
Peripheral Artery Disease
By Absorption Rate
Slow Absorption Rate
Fast Absorption Rate
By End User
Hospitals
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Bioabsorbable Stents Market Size Summary

The bioabsorbable stents market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases, an aging population, and a rising number of obese individuals. These factors are contributing to a heightened demand for early diagnosis and treatment options, thereby expanding the market's scope. The market is characterized by the development and approval of new polymer-based stents, which are made from materials that can dissolve or be absorbed by the body, offering potential advantages in terms of safety and efficacy. The North American region currently leads the market, supported by technological advancements, a favorable reimbursement scenario, and a substantial patient pool suffering from cardiovascular conditions.

Despite the challenges posed by the COVID-19 pandemic, which temporarily disrupted cardiac surgery volumes, the market is expected to recover and grow steadily. Key players in the industry are focusing on innovation and the introduction of advanced stent systems to maintain their competitive edge. The market landscape is becoming increasingly competitive, with both major and mid-size companies striving to enhance their market presence through product innovations and strategic partnerships. As the demand for bioabsorbable stents continues to rise, driven by demographic and health trends, the market is anticipated to experience robust growth over the forecast period.

Explore More

Global Bioabsorbable Stents Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Introduction to Market Drivers and Restraints

    3. 1.3 Market Drivers

      1. 1.3.1 High Prevalence of Cardiovascular Diseases Globally

      2. 1.3.2 Steep Increase in Aging Population

      3. 1.3.3 Expanding Base of Obese Population

    4. 1.4 Market Restraints

      1. 1.4.1 Stringent Regulatory Scenario

      2. 1.4.2 High Device Cost

      3. 1.4.3 Safety Issues Related to Bioabsorbable Stents

    5. 1.5 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.5.1 Threat of New Entrants

      2. 1.5.2 Bargaining Power of Buyers/Consumers

      3. 1.5.3 Bargaining Power of Suppliers

      4. 1.5.4 Threat of Substitute Products

      5. 1.5.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product

      1. 2.1.1 Polymer-based Bioabsorbable Stents

      2. 2.1.2 Metal-based Bioabsorbable Stents

    2. 2.2 By Application

      1. 2.2.1 Coronary Artery Disease

      2. 2.2.2 Peripheral Artery Disease

    3. 2.3 By Absorption Rate

      1. 2.3.1 Slow Absorption Rate

      2. 2.3.2 Fast Absorption Rate

    4. 2.4 By End User

      1. 2.4.1 Hospitals

      2. 2.4.2 Other End Users

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle East & Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle East & Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Global Bioabsorbable Stents Market Size FAQs

The Global Bioabsorbable Stents Market size is expected to reach USD 1.08 billion in 2024 and grow at a CAGR of 8.76% to reach USD 1.63 billion by 2029.

In 2024, the Global Bioabsorbable Stents Market size is expected to reach USD 1.08 billion.

Bioabsorbable Stents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)